If IGF-1 remains too low or jumps too high, it may signal under- or over-treatment
The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)
(Ozempic/Wegovy) GLP-1 agonists are medications that lower blood sugar levels and promote weight loss
GLP-1 medications have shown promise in slowing the progression of kidney damage
[1] In terms of efficacy, ipamorelin has similar or higher potency compared to GHRP-6 in various animal models, but it stands out due to its unique lack of effect on other hormones such as prolactin, follicle stimulating hormone (FSH), luteinizing hormone (LH), PRL, and thyroid stimulating hormone (TSH)
1.0mg equals 5 units